In the patchwork quilt that is America post- Roe, chemical abortion is becoming the new battleground in the states. We discuss the new laws emerging on either side of the abortion pill issue, the looming decision of a Texas federal judge on whether to suspend the FDA’s approval of mifepristone, and how a group of hobby pilots are fly abortion patients out of states with bans. Plus, we discuss the new study showing hormonal birth control elevates the risk of breast cancer.
This week on the Pro-Life America podcast, we discuss how Democrats are rallying against protecting babies born alive during abortions and calling it “extreme.” Meanwhile, new research by the Abortion Survivors Network reveals that 1,900+ children are “potentially” surviving abortions each year in the U.S. – contradicting claims from the left that abortion survivors are rare. And as some states are setting up to become abortion tourist hotspots, some pharmacies are expressing hesitation over offering the abortion pill in response to the FDA’s decision last week.
This week on the Pro-Life America podcast, we discuss the recent changes to the regulations for chemical abortions and telemed abortions made by the FDA and how this fits in with the abortion industry’s vision for the future. But in an interesting twist, could CVS, Walgreens, and others be trying to squeeze out the abortion industry in the telemed abortion business?
This week, under the guise of women’s safety due to COVID, the FDA announced that women seeking an abortion pill will not be required to visit a doctor’s office or clinic. We discuss how the fight to abandon this requirement began, what it means for women and young girls and what the motivation for the abortion industry’s endorsement of RU-486 really is. (Hint: It’s not money.)